Home > Qtrly Results > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Quarterly Results Analysis [Dec2025]

NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
Audited
Sep2024
Audited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹66 Cr ₹44 Cr ₹284 Cr ₹52 Cr ₹37 Cr ₹32 Cr ₹244 Cr ₹43 Cr
Expenses ₹62 Cr ₹38 Cr ₹245 Cr ₹52 Cr ₹29 Cr ₹27 Cr ₹207 Cr ₹39 Cr
Operating Income ₹4 Cr ₹6 Cr ₹38 Cr ₹0 Cr ₹8 Cr ₹5 Cr ₹37 Cr ₹4 Cr
Other Income ₹2 Cr ₹2 Cr ₹2 Cr ₹4 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹3 Cr ₹2 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹2 Cr ₹3 Cr ₹36 Cr ₹2 Cr ₹4 Cr ₹1 Cr ₹34 Cr ₹2 Cr
Profit After Tax ₹2 Cr ₹3 Cr ₹35 Cr ₹1 Cr ₹3 Cr ₹1 Cr ₹33 Cr ₹2 Cr
EPS ₹0.84 ₹1.45 ₹19.62 ₹0.78 ₹1.39 ₹0.59 ₹17.55 ₹1.38
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) 0% 7% -9.4%
BOMBAY BURMAH TRADING CORPORATION 0.3% 6.3% -7.1%
KAVERI SEED COMPANY -6.4% 2.9% -13.9%
VENKYS (INDIA) -3.2% -3.3% -14.5%
BOMBAY SUPER HYBRID SEEDS 3.9% -2.5% -36.6%
INDO US BIOTECH 17.9% 40% -32.7%
MANGALAM GLOBAL ENTERPRISE -5.3% -2.1% -8.5%
HARRISONS MALAYALAM 11% 17.1% -22.5%
TIERRA AGROTECH -5.8% -17.2% -16.7%

NATH BIOGENES (INDIA) Quarterly Revenues

Revenues
Q-o-Q

50.42 %

Y-o-Y

78.88 %

Quarters Revenues % Change
Dec2025 ₹66 Cr
50.42
Sep2025 ₹44 Cr
-84.54
Jun2025 ₹284 Cr
445.91
Mar2025 ₹52 Cr
40.94
Dec2024 ₹37 Cr
14.54
Sep2024 ₹32 Cr
-86.80
Jun2024 ₹244 Cr
466.65
Mar2024 ₹43 Cr -

NATH BIOGENES (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

-41.44 %

Y-o-Y

-55.54 %

Quarters Operating Profit % Change
Dec2025 ₹4 Cr
-41.44
Sep2025 ₹6 Cr
-84.06
Jun2025 ₹38 Cr
9,169.73
Mar2025 ₹0 Cr
-94.86
Dec2024 ₹8 Cr
67.01
Sep2024 ₹5 Cr
-86.83
Jun2024 ₹37 Cr
830.12
Mar2024 ₹4 Cr -
Operating Margins
Q-o-Q

-61.06 %

Y-o-Y

-75.14 %

Quarters Operating Margin% % Change
Dec2025 5.42%
-61.06
Sep2025 13.92%
3.19
Jun2025 13.49%
1,607.59
Mar2025 0.79%
-96.38
Dec2024 21.8%
45.82
Sep2024 14.95%
-0.20
Jun2024 14.98%
64.07
Mar2024 9.13% -

NATH BIOGENES (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-41.66 %

Y-o-Y

-39.42 %

Quarters Profit After Tax % Change
Dec2025 ₹2 Cr
-41.66
Sep2025 ₹3 Cr
-92.18
Jun2025 ₹35 Cr
3,646.49
Mar2025 ₹1 Cr
-64.54
Dec2024 ₹3 Cr
137.97
Sep2024 ₹1 Cr
-96.66
Jun2024 ₹33 Cr
1,897.25
Mar2024 ₹2 Cr -
PAT Margins
Q-o-Q

-61.31 %

Y-o-Y

-66.20 %

Quarters PAT Margin(%) % Change
Dec2025 2.43 %
-61.31
Sep2025 6.28 %
-49.40
Jun2025 12.41 %
585.64
Mar2025 1.81 %
-74.83
Dec2024 7.19 %
107.80
Sep2024 3.46 %
-74.71
Jun2024 13.68 %
252.58
Mar2024 3.88 % -

NATH BIOGENES (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-42.07 %

Y-o-Y

-39.57 %

Quarters EPS % Change
Dec2025 ₹0.84
-42.07
Sep2025 ₹1.45
-92.61
Jun2025 ₹19.62
2,415.38
Mar2025 ₹0.78
-43.88
Dec2024 ₹1.39
135.59
Sep2024 ₹0.59
-96.64
Jun2024 ₹17.55
1,171.74
Mar2024 ₹1.38 -

You may also like the below Video Courses